Search

everythinglearnresearchcommunity

for

Search:↓

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

New cytokine-targeted therapies show promise for treating alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Blocking LFA-1 prevents hair loss in mice.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

CS12192 effectively treats alopecia areata with better safety than current options.

Different γδ T cell types have unique roles in causing alopecia areata.

Alopecia areata involves unique activation of certain immune cells.

Tridax procumbens plant parts boost immune response in mice.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Serotonin helps wounds heal faster.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.